Asia Pacific Sepsis Diagnostics Market Forecast to 2028

Asia Pacific Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology (Molecular Diagnostics {Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, Microarrays}, Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology), Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

Report Code : BMIRE00025658 | Region : Asia Pacific | Industry : Medical Device | Published Date : 10/Aug/2022

The APAC sepsis diagnostics market is expected to grow from US$ 131.79 million in 2021 to US$ 249.70 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028.

The rising need for rapid diagnostics for sepsis fueled the research activities among key players in recent years. Both the existing players and the start-ups in sepsis diagnostics are well supported financially by government and research organizations. For instance, in April 2020, Cytovale Inc. announced its partnership with the Biomedical Advanced Research and Development Authority (BARDA) for sepsis diagnosis in patients with respiratory infections, including COVID-19. The research was estimated to stand at US$ 5.9 million, with a contribution of approximately US$ 3.83 million by BARDA. Additionally, in an endeavor to shape the future of sepsis research, the National Institute of General Medical Sciences (NIGMS) intends to use the NIH SBIR/STTR program to support preclinical and clinical sepsis studies to develop improved diagnostic tools and therapies. Diagnostics companies are continuously securing funding to establish rapid sepsis diagnostic tests.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC sepsis diagnostics market. The APAC sepsis diagnostics market is expected to grow at a good CAGR during the forecast period.

APAC Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million )

APAC Sepsis Diagnostics Market Segmentation

The APAC sepsis diagnostics market is segmented based on product, technology, method, test type, pathogen, end user, and country. Based on product, the APAC sepsis diagnostics market is divided into instruments, reagents and assays, blood culture media, and software. The blood culture media dominated the APAC sepsis diagnostics market in 2021. Based on technology, the APAC sepsis diagnostics market is categorized into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment dominated the APAC sepsis diagnostics market in 2021. Based on method, the APAC sepsis diagnostics market is categorized into automated diagnostics and conventional diagnostics. The conventional diagnostics segment dominated the APAC sepsis diagnostics market in 2021. Based on test type, the APAC sepsis diagnostics market is categorized into point-of-care tests and laboratory tests. The laboratory tests segment dominated the APAC sepsis diagnostics market in 2021. Based on pathogen, the APAC sepsis diagnostics market is categorized into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment dominated the APAC sepsis diagnostics market in 2021. Based on end user, the APAC sepsis diagnostics market is categorized into hospitals, pathology and reference laboratories, and others. The hospitals segment dominated the APAC sepsis diagnostics market in 2021. Based on country, the APAC sepsis diagnostics market is segmented into Australia, China, India, Japan, South Korea, and the Rest of APAC. China dominated the APAC sepsis diagnostics market in 2021.

Key players operating in the APAC sepsis diagnostics market include Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; and T2 Biosystems, Inc. by Altair.

At 9.6% CAGR, the Asia Pacific Sepsis Diagnostics Market is speculated to be worth US$ 249.70 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the APAC sepsis diagnostics market was valued at US$ 131.79 million in 2021 and is expected to reach US$ 249.70 million by 2028, registering an annual growth rate of 9.6% from 2021 to 2028. High frequency of sepsis due to increasing nosocomial infections and expansion in demand for rapid diagnostic tests leading to increasing product launches are the critical factors attributed to the market expansion.

Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. To fulfill this rising demand, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. For instance, Inflammatix, a pioneering molecular diagnostics company, announced the publication of a health economic model that shows the use of the company's HostDxTM Sepsis test is cost-effective as compare to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in Emergency Departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test. The DxH 690T reported accurate results and improved turnaround time by reducing procedural steps and manual touchpoints, making it an ideal solution to help relieve some of sepsis disease burden. Thus, the rising in demand of rapid diagnostics test led to product launches and are expected to drive the sepsis diagnostics market during the forecast period. This is expected to drive the market during the forecast period.

On the contrary, loss of skilled professionals hurdles the growth of APAC sepsis diagnostics market.

Based on product, the APAC sepsis diagnostics market is divided into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held 43.7% market share in 2021, amassing US$ 57.53 million. It is projected to garner US$ 108.19 million by 2028 to expand at 9.4% CAGR during 2021–2028.

Based on technology, the APAC sepsis diagnostics market is categorized into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held 44.3% market share in 2021, amassing US$ 58.39 million. It is projected to garner US$ 108.74 million by 2028 to expand at 9.3% CAGR during 2021–2028. Further molecular diagnostics flow cytometry segment is further categorized into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, microarrays.

Based on Method, the APAC sepsis diagnostics market is categorized into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held 66.4% market share in 2021, amassing US$ 87.51 million. It is projected to garner US$ 163.94 million by 2028 to expand at 9.4% CAGR during 2021–2028

Based on test type, the APAC sepsis diagnostics market is divided into point-of-care tests and laboratory tests. The laboratory tests segment held 84.6% market share in 2021, amassing US$ 111.49 million. It is projected to garner US$ 210.34 million by 2028 to expand at 9.5% CAGR during 2021–2028

Based on pathogen, the APAC sepsis diagnostics market is divided into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held 79.6% market share in 2021, amassing US$ 104.91 million. It is projected to garner US$ 201.64 million by 2028 to expand at 9.8% CAGR during 2021–2028

Based on end user, the APAC sepsis diagnostics market is divided into hospitals, pathology and reference laboratories, and others. The hospitals segment held 47.8% market share in 2021, amassing US$ 63.04 million. It is projected to garner US$ 120.30 million by 2028 to expand at 9.7% CAGR during 2021–2028

Based on country, the APAC sepsis diagnostics market has been categorised into the Australia, China, India, Japan, South Korea, and Rest of APAC. Our regional analysis states that China captured 35.9% market share in 2021. It was assessed at US$ 47.35 million in 2021 and is likely to hit US$ 90.41 million by 2028, exhibiting a CAGR of 9.7% during the forecast period.

Key players dominating the APAC sepsis diagnostics market are Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; and T2 Biosystems, Inc. among others.

In Mar 2020, Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte RAPID. In April 2019, BD Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1   APAC Sepsis Diagnostics Market – By Product

1.3.2   APAC Sepsis Diagnostics Market – By Technology

1.3.3   APAC Sepsis Diagnostics Market – By Method

1.3.4   APAC Sepsis Diagnostics Market – By Test Type

1.3.5   APAC Sepsis Diagnostics Market – By Pathogen

1.3.6   APAC Sepsis Diagnostics Market – By End User

1.3.7   APAC Sepsis Diagnostics Market – By Country

2. Key Takeaways

3.   Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Sepsis Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1   APAC PEST Analysis

4.3 Experts Opinion

5. APAC Sepsis Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1   High Frequency of Sepsis due to Increasing Nosocomial Infections

5.1.2   Expansion in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches

5.2 Market Restraints

5.2.1   Loss of Skilled Professionals

5.3 Market Opportunities

5.3.1   Development in Funding and Support for Sepsis Diagnostics Research

5.4 Future Trends

5.4.1   Increasing Technological Advancements in Sepsis Diagnosis

5.5 Impact Analysis

6. Sepsis Diagnostics Market– APAC Analysis

6.1 APAC Sepsis Diagnostics Market Revenue Forecast and Analysis

7. APAC Sepsis Diagnostics Market – By Product

7.1 Overview

7.2 APAC Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)

7.3 Instruments

7.3.1   Overview

7.3.2   Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Reagents and Assays

7.4.1   Overview

7.4.2   Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Blood Culture Media

7.5.1   Overview

7.5.2   Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Software

7.6.1   Overview

7.6.2   Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. APAC Sepsis Diagnostics Market – By Technology

8.1 Overview

8.2 APAC Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

8.3 Molecular Diagnostics

8.3.1   Overview

8.3.2   Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.1   Polymerase Chain Reaction

8.3.2.1.1   Overview

8.3.2.1.2   Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.2   Peptide Nucleic Acid-Fluorescent in Situ Hybridization

8.3.2.2.1   Overview

8.3.2.2.2   Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.3   Syndromic Panel-Based Testing

8.3.2.3.1   Overview

8.3.2.3.2   Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.4   Microarrays

8.3.2.4.1   Overview

8.3.2.4.2   Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4 Flow Cytometry

8.4.1   Overview

8.4.2   Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5 Microfluidics

8.5.1   Overview

8.5.2   Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6 Immunoassay

8.6.1   Overview

8.6.2   Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7 Biomarkers

8.7.1   Overview

8.7.2   Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8 Microbiology

8.8.1   Overview

8.8.2   Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. APAC Sepsis Diagnostics Market – By Method

9.1 Overview

9.2 APAC Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

9.3 Automated Diagnostics

9.3.1   Overview

9.3.2   Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4 Conventional Diagnostics

9.4.1   Overview

9.4.2   Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.   APAC Sepsis Diagnostics Market – By Test Type

10.1   Overview

10.2   APAC Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

10.3   Point-of-Care Tests

10.3.1 Overview

10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4   Laboratory Tests

10.4.1 Overview

10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.   APAC Sepsis Diagnostics Market – By Pathogen

11.1   Overview

11.2   APAC Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

11.3   Bacterial Sepsis

11.3.1 Overview

11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.4   Fungal Sepsis

11.4.1 Overview

11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.5   Others

11.5.1 Overview

11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.   APAC Sepsis Diagnostics Market – By End User

12.1   Overview

12.2   APAC Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

12.3   Hospitals

12.3.1 Overview

12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.4   Pathology and Reference Laboratories

12.4.1 Overview

12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.5   Others

12.5.1 Overview

12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13.   APAC Sepsis Diagnostics Market – By Country Analysis

13.1   Asia Pacific: Sepsis Diagnostics Market

13.1.1 Overview

13.1.2 APAC: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

13.1.2.1 China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.1.1 China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.1.2 China: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.2.1.3 China: Sepsis Diagnostics Market, by Technology, 2019–2028 (USD Million)

13.1.2.1.3.1 China Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.2.1.4 China: Sepsis Diagnostics Market, by Method, 2019–2028 (USD Million)

13.1.2.1.5 China: Sepsis Diagnostics Market, by Test Type, 2019–2028 (USD Million)

13.1.2.1.6 China: Sepsis Diagnostics Market, by Pathogen, 2019–2028 (USD Million)

13.1.2.1.7 China: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.2.2 Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.2.1 Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.2.2 Japan: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.2.2.3 Japan: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.2.2.3.1 Japan Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.2.2.4 Japan: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.2.2.5 Japan: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.2.2.6 Japan: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.2.2.7 Japan: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.2.3 India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.3.1 India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.3.2 India: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.2.3.3 India: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.2.3.3.1 India Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.2.3.4 India: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.2.3.5 India: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.2.3.6 India: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.2.3.7 India: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.2.4 Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.4.1 Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.4.2 Australia: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.2.4.3 Australia: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.2.4.3.1 Australia Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.2.4.4 Australia: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.2.4.5 Australia: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.2.4.6 Australia: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.2.4.7 Australia: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.2.5 South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.5.1 South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.5.2 South Korea: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.2.5.3 South Korea: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.2.5.3.1 South Korea Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.2.5.4 South Korea: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.2.5.5 South Korea: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.2.5.6 South Korea: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.2.5.7 South Korea: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.2.6 Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.6.1 Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.6.2 Rest of Asia Pacific: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.2.6.3 Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.2.6.3.1 Rest of APAC Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.2.6.4 Rest of Asia Pacific: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.2.6.5 Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.2.6.6 Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.2.6.7 Rest of Asia Pacific: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

14.   Sepsis Diagnostics Market–Industry Landscape

14.1   Overview

14.2   Growth Strategies in the Sepsis Diagnostics Market (%)

14.3   Organic Developments

14.3.1 Overview

14.4   Inorganic Developments

14.4.1 Overview

15.   Company Profiles

15.1   Abbott

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2   F. HOFFMANN-LA ROCHE LTD.

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3   Immunexpress Inc.

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4   BD

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5   Danaher (Beckman Coulter)

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6   Luminex Corporation

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7   THERMO FISHER SCIENTIFIC INC.

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8   bioMerieux SA

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9   T2 Biosystems, Inc.

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

16.   Appendix

16.1   About The Insight Partners

16.2   Glossary of Terms

LIST OF TABLES.

Table 1. China: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 2. China: Sepsis Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)

Table 3. China: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and forecast to 2028 (USD Million)

Table 4. China: Sepsis Diagnostics Market, by Method– Revenue and forecast to 2028 (USD Million)

Table 5. China: Sepsis Diagnostics Market, by Test Type– Revenue and forecast to 2028 (USD Million)

Table 6. China: Sepsis Diagnostics Market, by Pathogen – Revenue and forecast to 2028 (USD Million)

Table 7. China: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 8. Japan: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 9. Japan: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 10.   Japan: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 11.   Japan: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 12.   Japan: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 13.   Japan: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 14.   Japan: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 15.   India: Sepsis Diagnostics Market, By Product– Revenue and Forecast to 2028(USD Million)

Table 16.   India: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 17.   India: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 18.   India: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 19.   India: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 20.   India: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 21.   India: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 22.   Australia: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 23.   Australia: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 24.   Australia: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 25.   Australia: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 26.   Australia: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 27.   Australia: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 28.   Australia: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 29.   South Korea: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 30.   South Korea: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 31.   South Korea: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 32.   South Korea: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 33.   South Korea: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 34.   South Korea: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 35.   South Korea: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 36.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 37.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 38.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 39.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Method– Revenue and Forecast to 2028 (USD Million)

Table 40.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type– Revenue and Forecast to 2028 (USD Million)

Table 41.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen– Revenue and Forecast to 2028 (USD Million)

Table 42.   Rest of Asia Pacific: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 43.   Organic Developments in the Sepsis Diagnostics Market

Table 44.   Inorganic Developments in the Sepsis Diagnostics Market

Table 45.   Glossary of Terms

LIST OF FIGURES.

Figure 1. APAC Sepsis Diagnostics Market Segmentation

Figure 2. APAC Sepsis Diagnostics Market, By Country

Figure 3. APAC Sepsis Diagnostics Market Overview

Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market

Figure 5. China is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. APAC: PEST Analysis

Figure 7. APAC Experts Opinion

Figure 8. APAC Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints

Figure 9. APAC Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.   APAC Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)

Figure 11.   APAC Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.   APAC Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.   APAC Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.   APAC Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.   APAC Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

Figure 16.   APAC Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.   APAC Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18.   APAC Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.   APAC Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.   APAC Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.   APAC Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.   APAC Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23.   APAC Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24.   APAC Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.   APAC Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26.   APAC Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

Figure 27.   APAC Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28.   APAC Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29.   APAC Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

Figure 30.   APAC Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.   APAC Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32.   APAC Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

Figure 33.   APAC Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34.   APAC Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35.   APAC Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 36.   APAC Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

Figure 37.   APAC Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 38.   APAC Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 39.   APAC Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 40.   Asia Pacific: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 41.   APAC: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 42.   China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 43.   Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 44.   India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 45.   Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 46.   South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 47.   Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 48.   Growth Strategies in the Sepsis Diagnostics Market (%)

".

The List of Companies - Asia Pacific Sepsis Diagnostics Market

● Abbott

● F. HOFFMANN-LA ROCHE LTD.

● Immunexpress Inc.

● BD

● Danaher (Beckman Coulter)

● Luminex Corporation

● THERMO FISHER SCIENTIFIC INC.

● bioMerieux SA

● T2 Biosystems, Inc

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC sepsis diagnostics market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the APAC sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the APAC sepsis diagnostics market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP